EP2094275A2 — Methods and formulations for improved bioavailability of antiprogestins
Assigned to Repros Therapeutics Inc · Expires 2009-09-02 · 17y expired
What this patent protects
Compositions comprising an antiprogestin and having improved bioavailability are provided. In one aspect, compositions comprising particles of an antiprogestin deposited on a carrier substrate are provided. In another aspect, compositions comprising a micronized antiprogestin are…
USPTO Abstract
Compositions comprising an antiprogestin and having improved bioavailability are provided. In one aspect, compositions comprising particles of an antiprogestin deposited on a carrier substrate are provided. In another aspect, compositions comprising a micronized antiprogestin are provided. Also provided is the use of compositions comprising an antiprogestin and having improved bioavailability for the treatment of endometriosis, uterine fibroids, dysmenorrhea, and meningiomas.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.